Literature DB >> 1454812

Probucol inhibits neointimal thickening and macrophage accumulation after balloon injury in the cholesterol-fed rabbit.

G A Ferns1, L Forster, A Stewart-Lee, M Konneh, J Nourooz-Zadeh, E E Anggård.   

Abstract

Restenosis is a frequent long-term complication after balloon angioplasty. Although smooth muscle cells form the major constituent of the occluding lesion, macrophage-derived foam cells are usually also present in high abundance. The latter have the potential to accelerate the rate of reocclusion because they elaborate many potent cytokines and growth factors, which may act to either recruit cells into the neointima or cause neointimal cell proliferation. Macrophage-derived foam-cell formation depends upon the uptake of modified low density lipoprotein via a scavenger receptor-mediated pathway. Foam-cell formation is accompanied by the release of smooth muscle cell mitogens and chemoattractants. We have examined the effects of probucol, a lipid-soluble antioxidant, in the balloon-catheterized carotid artery of the cholesterol-fed rabbit to evaluate the importance of oxidative processes in restenosis. After 5 weeks, serum cholesterol levels were 32% lower (P < 0.05) in rabbits fed 1% probucol with 2% cholesterol, compared with those receiving cholesterol alone. Probucol inhibited neointimal macrophage accumulation by 68% (P < 0.001), reduced absolute intimal size by 51% (P < 0.05), and reduced the intima/media thickness ratio by 51%. These inhibitory effects were directly related to serum probucol concentrations and appeared to be unrelated to probucol's hypocholesterolemic activity. These data suggest that reactive oxygen species may be involved in the intimal response to injury and that antioxidants, such as probucol, may be therapeutically useful as inhibitors of restenosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1454812      PMCID: PMC50540          DOI: 10.1073/pnas.89.23.11312

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

Review 1.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

2.  Probucol attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits.

Authors:  A Daugherty; B S Zweifel; G Schonfeld
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

3.  Concentration-dependent antioxidant activity of probucol in low density lipoproteins in vitro: probucol degradation precedes lipoprotein oxidation.

Authors:  R L Barnhart; S J Busch; R L Jackson
Journal:  J Lipid Res       Date:  1989-11       Impact factor: 5.922

4.  Inhibition by probucol of interleukin 1 secretion and its implication in atherosclerosis.

Authors:  G Ku; N S Doherty; J A Wolos; R L Jackson
Journal:  Am J Cardiol       Date:  1988-07-25       Impact factor: 2.778

5.  Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit.

Authors:  T E Carew; D C Schwenke; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

6.  Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia.

Authors:  T Kita; Y Nagano; M Yokode; K Ishii; N Kume; A Ooshima; H Yoshida; C Kawai
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

7.  Morphogenesis and clinicopathologic characteristics of recurrent carotid disease.

Authors:  G P Clagett; M Robinowitz; J R Youkey; D F Fisher; R E Fry; S I Myers; E L Lee; G J Collins; R Virmani
Journal:  J Vasc Surg       Date:  1986-01       Impact factor: 4.268

8.  Restenosis after successful coronary angioplasty in patients with single-vessel disease.

Authors:  P P Leimgruber; G S Roubin; J Hollman; G A Cotsonis; B Meier; J S Douglas; S B King; A R Gruentzig
Journal:  Circulation       Date:  1986-04       Impact factor: 29.690

9.  Immunocytochemical analysis of cellular components in atherosclerotic lesions. Use of monoclonal antibodies with the Watanabe and fat-fed rabbit.

Authors:  T Tsukada; M Rosenfeld; R Ross; A M Gown
Journal:  Arteriosclerosis       Date:  1986 Nov-Dec

10.  Prevention of atherosclerotic progression in Watanabe rabbits by probucol.

Authors:  T Kita; Y Nagano; M Yokode; K Ishii; N Kume; S Narumiya; C Kawai
Journal:  Am J Cardiol       Date:  1988-07-25       Impact factor: 2.778

View more
  10 in total

Review 1.  New approaches to the prevention of atherosclerosis.

Authors:  M Naito; T Hayashi; A Iguchi
Journal:  Drugs       Date:  1995-09       Impact factor: 9.546

Review 2.  Antioxidants and atherosclerosis: emerging drug therapies.

Authors:  Jean-Claude Tardif
Journal:  Curr Atheroscler Rep       Date:  2005-02       Impact factor: 5.113

Review 3.  The mechanisms of coronary restenosis: insights from experimental models.

Authors:  G A Ferns; T Y Avades
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

4.  Expression of a constitutive NF-kappa B-like activity is essential for proliferation of cultured bovine vascular smooth muscle cells.

Authors:  R E Bellas; J S Lee; G E Sonenshein
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

5.  Decreased neointimal formation in Nox2-deficient mice reveals a direct role for NADPH oxidase in the response to arterial injury.

Authors:  Zhiping Chen; John F Keaney; Eberhard Schulz; Bruce Levison; Lian Shan; Masashi Sakuma; Xiaobin Zhang; Can Shi; Stanley L Hazen; Daniel I Simon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-17       Impact factor: 11.205

Review 6.  Antioxidants: the good, the bad and the ugly.

Authors:  Jean-Claude Tardif
Journal:  Can J Cardiol       Date:  2006-02       Impact factor: 5.223

7.  Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice.

Authors:  F Liao; A Andalibi; J H Qiao; H Allayee; A M Fogelman; A J Lusis
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

Review 8.  Redox processes underlying the vascular repair reaction.

Authors:  Paulo F Leite; Marcel Liberman; Fábio Sandoli de Brito; Francisco R M Laurindo
Journal:  World J Surg       Date:  2004-02-17       Impact factor: 3.352

9.  Effect of alpha-tocopherol on restenosis after angioplasty in a model of experimental atherosclerosis.

Authors:  A M Lafont; Y C Chai; J F Cornhill; P L Whitlow; P H Howe; G M Chisolm
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

10.  Cathepsin K Deficiency Prevents the Aggravated Vascular Remodeling Response to Flow Cessation in ApoE-/- Mice.

Authors:  Marjo M P C Donners; Lili Bai; Suzanne P M Lutgens; Erwin Wijnands; Jason Johnson; Leon J Schurgers; Cong-Lin Liu; Mat J A P Daemen; Kitty B J M Cleutjens; Guo-Ping Shi; Erik A L Biessen; Sylvia Heeneman
Journal:  PLoS One       Date:  2016-09-16       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.